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Introduction: exercise in patients with intermittent claudication causes systemic effects, the consequences of which are
unknown. This study investigates whether successful PTA reverses the systemic effects.
Patients and Methods: ten patients with IC were recruited prior to PTA. Having emptied their bladders and rested for
1 h, pre-exercise blood and urine samples were collected. Patients underwent treadmill exercise to maximum walking time
and blood samples were collected at 10, 20 and 30 min. A second urine sample was collected at 60 min. Total antioxidant
capacity (TAC) and von Willebrands Factor (vWF) were measured in blood and albumin/creatinine ratio (ACR) and
retinol binding protein/creatinine ratio (RBP/Cr) in urine. Patients were recalled 2 weeks after successful angioplasty
and the protocol repeated. Following PTA patients walked for a maximum of 5 min.
Results: there was no significant change in vWF. Exercise in claudicants induced a significant increase in median ACR
(pre/post exercise=0.85; p=0.03) and in median RBP/Cr (pre/post exercise=1.8; p=0.04). These changes were no
longer evident after successful PTA. TAC was significantly different before and after angioplasty at all time intervals.
Conclusion: successful PTA reverses glomerular effects of exercise in claudicants. Future work should investigate the
use of PTA in conjunction with exercise in the treatment of peripheral vascular disease.
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Introduction when compared to normal controls following exercise.
Subsequent data8–10 suggested that claudication may
The debate regarding the best treatment for in- cause systemically harmful effects with a generalised
termittent claudication stimulates much interest increase in vascular permeability. This systemic re-
among surgeons, interventional radiologists, scientists sponse to claudication may contribute to the increased
and purchasers of health care1,2 but still lacks ex- mortality seen in patients with intermittent clau-
perimental and clinical evidence. dication. Vascular bypass surgery reduced such ef-
Exercise therapy has been shown to ‘‘normalise’’ fects.10,11
blood rheology in claudicants.3 It was suggested that Direct evidence of endothelial damage consequent
exercise training should be looked on as a form of on exercise in claudicants has only been demonstrated
‘‘hemorrheologic therapy’’ but exercise induced isch- in animal models using electron microscopy12 but cir-
aemia is followed by reperfusion which may add to cumstantial evidence of endothelial injury from human
the problem by incurring both local and remote organ studies has emerged with the use of biochemical
injury.4 The cycles of ischaemia and reperfusion that markers such as von Willebrand’s factor13,14 thrombo-
occur when patients with intermittent claudication modulin,15 tissue plasminogen activator and plasm-
exercise is a topic that has stimulated much research inogen activator inhibitor.14 Endothelial injury was not
interest. demonstrated in all of these reports but is possibly
At the same time as Housley6 and Coffman6 in- one of a hierarchy of events that occur following
structed clinicans to treat claudicants conservatively exercise in claudicants.
other data suggested exercise in claudicants may not The renal reabsorbtive mechanisms for albumin
be entirely benign.7 In a small group of patients a work at near maximum capacity under normal con-
significant rise in urinary albumin excretion was noted
ditions so a small rise in the amount of albumin
crossing the glomerulus will overwhelm the re-
absorbtive mechanisms and result in albumin ap-∗ Please address all correspondence to: D. R. Lewis, 2 Queens Parade,
Brandon Hill, Bristol BS1 5XJ, U.K. pearing in the urine. As well as having higher resting
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Table 1. Change in Albumin/Creatinine (ACR) ratio induced byalbumin/creatinine ratios (ACRs)10 exercise produces
exercise before and after successful PTA.a significantly higher rise in ACR in claudicants than
(Median) Pre-exercise Post-exercise  in ACRhealthy controls10,16 Other renal effects of exercise in
claudicants have not been studied previously. Retinol
Pre PTA 1.85 2.7 1.25binding protein (RBP) is a 21 kDa vitamin A trans- Post PTA 1.9 2.0 0.2
porting protein that has been established as a reliable
marker in urine of renal tubular function.17,18 Ratios
with creatinine were calculated so that acute changes following exercise. Serum and plasma were stored at
in glomerular filtration rate were accounted for. −70°C until analysis in one batch. A second urine
Exercise in patients with intermittent claudication sample was collected and stored 1 h after exercise.
has been suggested to increase oxidant stress and Exercise was on a treadmill at 3 km/h at a 10° incline
the evidence for this has been reviewed.19 Complex to the maximum walking distance (MWD). Ankle/
antioxidant systems are needed to minimize damage brachial pressure indices were measured in patients
to biological compounds. These antioxidant systems and exercise induced fall in ABPI calculated. Two
include enzymes, macromolecules and a number of weeks following successful angioplasty patients were
small molecules including ascorbic acid, uric acid, invited to reattend and the same process was repeated.
bilirubin and protein thiols.20,21 The variety of com- Successful angioplasty was defined as a procedure
ponents in serum with potential antioxidant capacity that provided symptomatic relief, increased the resting
has led to the widespread use of assays measuring ABPI by at least 0.2 and improved the exercise induced
total antioxidant capacity thereby providing a clin- fall in ABPI. Following angioplasty patients were ex-
ically useful global measure. The different methods ercised for a maximum of 5 min. It was considered
have been compared and pitfalls noted.22–24 inappropriate to exercise an elderly group of patients
Exercise programmes can reduce inflammatory with known cardiovascular disease to near exhaustion.
markers in claudicants over time25 but the effects of The protocol was chosen because patients following
percutaneous transluminal angioplasty on acute PTA did find 5 min walking on the treadmill strenuous
markers of inflammation has not been studied to date. exercise.
This study has not attempted to determine the best Urine samples were analysed for albumin (Im-
treatment for patients with intermittent claudication, munoturbidimetric method, DiaSorin, Stillwater,
it has investigated whether the systemic effects of U.S.A.), retinol binding protein (ELISA, Dako, High
claudication are reversed by successful PTA. Wycombe, U.K.) and creatinine (kinetic Jaffe method,
Roche Diagnostic Systems, Lewes, U.K.); ratios to cre-
atinine were calculated to correct for variations in
urinary flow rate. Blood samples were analysed for
Patients and Methods von Willebrand Factor (ELISA, Dako, High Wycombe,
U.K.) and total antioxidant capacity (colourimetricThe project was approved by the regional ethics com- method, Randox Laboratories Ltd., Crumlin U.K.).mittee. Patients with intermittent claudication were Results are expressed as medians and statistical ana-recruited from the vascular outpatients department. lysis was by Wilcoxon signed rank test.This was facilitated by a one stop clinic where a duplex
scan of the lower limb vasculature, including aortoiliac
vessels, was performed at the patient’s first attendance
thereby allowing recruitment of patients who had Results
lesions potentially suitable for angioplasty.
Patients were invited to attend the vascular studies Ten patients were recruited with a median (range) age
of 67 (44–81) years and a male to female ratio of 4:1.unit where informed consent was obtained. Subjects
were asked not to exercise on the day of appointment Four patients admitted to being current smokers, 6
were on medication for hypertension and 2 had dia-or induce claudication pain. On arrival subjects emp-
tied their bladders followed by 1 h rest. After this a betes mellitus. All patients were stable claudicants
with a median duration of symptoms of 18 monthsfirst urine sample was collected and stored at −70°C.
Ten millilitre venous blood samples were collected and all were taking aspirin.
Pre angioplasty the median (range) MWD was 133from a cubital fossa vein using a no tourniquet tech-
nique and discarding the first 2 ml of blood drawn. (97–239) m which improved to 250 (112–250) m fol-
lowing successful PTA. The exercise test followingBlood samples were collected before exercise, im-
mediately following exercise and at 10, 20 and 30 min PTA terminated at 250 m as part of the study protocol.
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Table 2. Change in RBP/Creatinine ratio induced by exercise
before and after successful PTA.
(Median) Pre-exercise Post-exercise  in RBP/Cr
Pre PTA 10.6 12.4 3.6
Post PTA 25.95 18.1 −7.85
Fig. 2. Exercise induced change in von Willebrand’s Factor (%) before
and after successful PTA (median values plotted with interquartile
ranges in table below).
p=ns at each time interval.
Interquartile Pre 0 10 20 30
range
Pre PTA 155–181 164–191 157–183 155–187 146–177
Post PTA 111–173 112–177 103–175 100–164 108–165
Fig. 1. Exercise induced change in total antioxidant capacity (mmol/
L) before and after successful PTA (median values plotted with
interquartile ranges in the table below). PTA reverses these glomerular effects induced by ex-
Wilcoxon p<0.05 at each time interval. ercise in patients with intermittent claudication. Total
antioxidant capacity falls after successful PTA whichInterquartile Pre 0 10 20 30
may be explained by downregulation of the anti-range
oxidant system in response to removal of a significant
Pre PTA 1.26–1.45 1.26–1.52 1.27–1.49 1.26–1.50 1.28–1.51 oxidant stimulus or altered metabolism of antioxidantsPost PTA 1.17–1.29 1.19–1.35 1.16–1.30 1.22–1.28 1.14–1.29
most importantly serum urate.22
Smoking, diabetes mellitus and hypertension may
influence some of the parameters measured in thisMedian (range) fall in ABPI was 0.34 (0.2–0.68) from a study. Although there was heterogeneity within themedian (range) resting ABPI of 0.74 (0.5–1). Following patient group with 2 diabetics, 4 smokers and 6 treatedPTA resting ABPI had improved to a median (range) hypertensives, these conditions were present both be-of 0.95 (0.83–1) and the exercise induced fall had been fore and after angioplasty. Furthermore open re-reduced to a median (range) of 0.04 (0–0.59). cruitment allowed for a sample of patients that wasWith regard to urinary ACR and RBP/Cr there were representative of patients attending vascular surgicalstatistically significant rises in these ratios induced by clinics.exercise before angioplasty. Median change in ACR Walking exercise as a treatment for IC was firstconsequent on exercise was 0.8 (p<0.05) and change suggested by Erb in 189826 since when ‘‘treating clau-in RBP/Cr was 1.8 (p<0.05). These changes were no dication in five words’’5 with the advice to ‘‘stoplonger evident after successful PTA (p=ns) (Tables 1 smoking and keep walking’’ has been accepted as theand 2). primary treatment for IC.6 Meta-analysis27 suggestsThe total antioxidant capacity was significantly that the optimal exercise programme involves walkinghigher before compared to after angioplasty at all time to near maximum pain for at least 6 months andintervals (Fig. 1). There were no significant differences concludes that exercise regimens should be a routineobserved in vWF consequent to angioplasty (Fig. 2). part of treatment for claudicants. These conclusions
were supported by The Cochrane Peripheral Vascular
Diseases Group.28 Despite these recommendations
there is a risk that exercise may also have harmfulDiscussion
systemic effects mediated through reactive oxygen
species and activated neutrophils. Neutrophils areThis study has demonstrated that exercise in clau-
dicants causes tubular as well as glomerular dys- central to the pathophysiology of ischaemia–
reperfusion injury and there is evidence that exercisefunction in the kidney. It has also shown that successful
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